North Carolina Administrative Code › Title 10A - HEALTH AND HUMAN SERVICES › Chapter 43 - PERSONAL HEALTH › Subchapter K - NEWBORN SCREENING FOR CRITICAL CONGENITAL HEART DEFECTS › Section 43K .0101 - DEFINITIONS

Current through Register Vol. 39, No. 2, July 15, 2024
As used in this Section:
(1) "Neonate" means any term infant less than
				28 days of age or any preterm infant less than 28 days corrected age.
(2) "Infant" means a person who is less than
				365 days of age.
(3) "Critical
				congenital heart defects" (CCHD) means heart conditions present at birth that
				are dependent on therapy to maintain patency of the ductus arteriosus for
				either adequate pulmonary or systemic blood flow and that require catheter or
				surgical intervention in the first year of life. Critical congenital heart
				defects are associated with significant morbidity and mortality and may include
				hypoplastic left heart syndrome, pulmonary atresia, tetralogy of Fallot, total
				anomalous pulmonary venous return, transposition of the great arteries,
				tricuspid atresia, and truncus arteriosus.
(4) "Medical facility" means a free-standing
				birthing center, licensed hospital, or licensed ambulatory surgery center where
				scheduled or emergency births occur or where inpatient neonatal services are
				provided.
(5) "Pulse oximetry"
				means a non-invasive transcutaneous assessment of arterial oxygen saturation
				using near infrared spectroscopy. This screening test measures with high
				reliability and validity the percentage of hemoglobin that is oxygenated, also
				known as the blood oxygen saturation.
(6) "Positive screening" means the final
				result is a failed or abnormal pulse oximetry screening for critical congenital
				heart defects for a neonate or infant using a screening protocol based on the
				most current American Academy of Pediatrics and American Heart Association
				(AAP/AHA) recommendations. This includes neonates or infants who have not yet
				been confirmed to have critical congenital heart defects or have other
				conditions to explain abnormal pulse oximetry results. A copy of the
				recommendations is available for inspection at the NC Division of Public
				Health, Women's and Children's Health Section, Children and Youth Branch, 5601
				Six Forks Road, Raleigh, NC 27609. In addition, the recommendations can be
				accessed at the American Academy of Pediatrics website at:
http://pediatrics.aappublications.org/content/128/5/e1259.full.pdf+html?sid=85e81711-f9b8-43d1-a352-479168895a72
.
(7) "Negative screening" means the final
				result is a passed or normal pulse oximetry screening for critical congenital
				heart defects for a neonate or infant using a screening protocol based on the
				most current AAP/AHA recommendations.
(8) "Attending providers of the neonate or
				infant" means the health care providers, such as pediatricians, family
				physicians, physician assistants, midwives, nurse practitioners,
				neonatologists, and other specialty physicians, who perform neonatal and infant
				assessments and review positive and negative pulse oximetry screening results
				to perform an evaluation and to create a plan of care for the neonate or infant
				prior to discharge from the care of the health care provider. This includes
				health care providers who attend to neonates or infants in hospitals,
				free-standing birthing centers, homes, or other locations.
Authority
				  G.S.
				  130A-125;
Temporary Adoption Eff.
				  July 25, 2014;
Eff. April 1,
				  2015.